LIXTE Biotechnology Acquires Liora Technologies Europe Ltd

Burlington Medical (Peninsula Capital Partners portfolio) Acquires Lite Tech (XenoLite)

June 28, 2022

Medical Devices

Burlington Medical, a portfolio company of Peninsula Capital Partners, has acquired Lite Tech, Inc. (d/b/a XenoLite), a Norristown, Pennsylvania manufacturer of lightweight, lead-free radiation-protective aprons and related products. The deal is an add-on to the Burlington platform and expands its manufacturing capabilities and product offering in the healthcare radiation-protection market, creating what Burlington describes as the world's largest manufacturer of radiation-protective aprons.

Full-Life Technologies Acquires Focus‑X Therapeutics

November 28, 2022

Biotechnology

Full‑Life Technologies, a global radiotherapeutics company, agreed to acquire New Jersey‑based Focus‑X Therapeutics to expand its peptide‑focused radiopharmaceutical pipeline. Focus‑X shareholders are eligible for an upfront payment plus up to $245 million in development, regulatory and sales milestones and royalties; the deal was expected to close in Q1 2023.

SHINE Technologies Acquires Lantheus' SPECT Business

January 2, 2026

Pharmaceuticals

SHINE Technologies has completed the acquisition of Lantheus' SPECT business, including the North Billerica, Massachusetts SPECT manufacturing facility and a portfolio of diagnostic radiopharmaceuticals (TechneLite, Cardiolite, NEUROLITE, Xenon Xe-133). SHINE named Michael Rossi CEO of SHINE SPECT USA, LLC and said the acquisition expands its nuclear medicine manufacturing capabilities and integrates with its Chrysalis Mo-99 production to strengthen isotope supply chain security.

Warburg Pincus and Tilia Acquire FlexXray from Levine Leichtman Capital Partners

July 26, 2021

Food & Beverage

Warburg Pincus and Tilia Holdings have acquired FlexXray, a leading provider of x-ray inspection and recovery services for the food industry, from Levine Leichtman Capital Partners. The investment is intended to support FlexXray's growth and expansion of its food-safety inspection capabilities and geographic reach; financial terms were not disclosed.

Telix Pharmaceuticals Acquires ARTMS Inc.

March 5, 2024

Pharmaceuticals

Telix Pharmaceuticals Limited has completed the acquisition of ARTMS Inc., a Burnaby, British Columbia-based developer of cyclotron-based isotope production technology and the QUANTM Irradiation System (QIS). The deal strengthens Telix's vertical integration and supply-chain control for key diagnostic and therapeutic radioisotopes (including 89Zr, 68Ga, 99mTc and 64Cu) to support its commercial products and pipeline.

Exosens Acquires LR Tech

September 2, 2024

Manufacturing

Exosens (Euronext: EXENS) has completed the acquisition of Quebec City–based LR Tech, a developer and manufacturer of FTIR spectroradiometers. The purchase adds FTIR instruments to Exosens’ high-performance instrumentation portfolio—strengthening its offering for defense, aerospace, environmental and scientific research markets and supporting Exosens’ bolt-on growth strategy.